AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
185.46
-0.55 (-0.30%)
At close: Jun 18, 2025
104.43%
Market Cap 53.24B
Revenue (ttm) 26.27B
Net Income (ttm) 3.12B
Shares Out 280.00M
EPS (ttm) 11.15
PE Ratio 17.06
Forward PE 12.64
Dividend 4.00 (2.10%)
Ex-Dividend Date Mar 27, 2025
Volume 203,812
Average Volume 373,557
Open 186.00
Previous Close 186.01
Day's Range 180.52 - 187.00
52-Week Range 85.50 - 220.02
Beta 0.31
RSI 48.47
Earnings Date Aug 26, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.

Financial Statements

News

There is no news available yet.